Active comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 (SGLT2) inhibitors.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15178
Abstract: INTRODUCTION Disproportionality analysis is a common pharmacovigilance tool to detect safety signals of type 2 diabetes medications from spontaneous drug reporting databases. OBJECTIVE To demonstrate the impact of using the active-comparator restricted disproportionality analysis (ACR-DA),… read more here.
Keywords: disproportionality analysis; comparator; sglt2 inhibitors; aror ... See more keywords